We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
276
CALL
Alnylam Pharmaceuticals
ALNY
$29B
$62K 0.01%
+2,500
New +$355K
APLS
277
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$62K 0.01%
4,200
SPY icon
278
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$61K 0.01%
11,400
+10,000
+714% +$4.1M
BNIXR
279
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$61K 0.01%
470,157
+10,399
+2% +$1.41K
CLINW
280
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$61K 0.01%
+435,400
New +$91.6K
DCRDW
281
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$59K 0.01%
294,479
+195,694
+198% +$85.7K
CYCUW
282
Cycurion Inc Warrant
CYCUW
$330K
$58K 0.01%
+481,056
New +$65.5K
TCDA
283
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$58K 0.01%
+12,800
New +$122K
ASCAR
284
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
$56K 0.01%
293,698
+48,698
+20% +$7.79K
SPY icon
285
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$55K 0.01%
10,000
-101,800
-91% -$41.7M
SOC.WS
286
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$55K 0.01%
341,612
+228,751
+203% +$46K
NFNT.WS
287
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$55K 0.01%
229,158
+128,033
+127% +$40.4K
TETEW
288
DELISTED
Technology & Telecommunication Acquisition Corporation Warrant
TETEW
$54K 0.01%
670,116
+175,401
+35% +$24.9K
GDS icon
289
CALL
GDS Holdings
GDS
$6.29B
$53K 0.01%
14,600
GRMLW
290
Greenland Mines Ltd Warrant
GRMLW
$53K 0.01%
+751,089
New +$71.7K
SCUA.WS
291
DELISTED
Sculptor Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SCUA.WS
$52K 0.01%
227,900
-22,907
-9% -$5.18K
DUETW
292
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$50K ﹤0.01%
436,601
-38,299
-8% -$6.07K
BTMD icon
293
Biote Corp
BTMD
$46.7M
$49K ﹤0.01%
+12,970
New +$102K
RFACW
294
DELISTED
RF Acquisition Corp. Warrants
RFACW
$49K ﹤0.01%
+539,252
New +$55.1K
OPA.WS
295
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$48K ﹤0.01%
601,949
+445,583
+285% +$274K
EVLVW
296
DELISTED
Evolv Technologies Warrant
EVLVW
$47K ﹤0.01%
121,478
+4,310
+4% +$1.51K
MO icon
297
CALL
Altria Group
MO
$109B
$47K ﹤0.01%
+141,900
New +$7.35M
BFAC.WS
298
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$46K ﹤0.01%
+255,300
New +$60.4K
HAL icon
299
PUT
Halliburton
HAL
$28B
$43K ﹤0.01%
32,200
MRK icon
300
CALL
Merck
MRK
$323B
$42K ﹤0.01%
+12,300
New +$1.09M

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.